PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.56%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-79.23%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
-99.88%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-74.55%
Operating expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-74.55%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-99.95%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
609.47%
D&A change of 609.47% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
90.56%
EBITDA change of 90.56% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
74.50%
Income change of 74.50% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
136.63%
Other expenses change of 136.63% versus flat Healthcare. Walter Schloss would verify control.
91.74%
Income change of 91.74% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-502.21%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
91.74%
Income change of 91.74% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
91.71%
EPS change of 91.71% versus flat Healthcare. Walter Schloss would verify quality.
91.71%
Diluted EPS change of 91.71% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.